Enhanced production of human full-length immunoglobulin G1 in the periplasm of Escherichia coli

[1]  S. Jung.  Tailoring immunoglobulin Fc for highly potent and serum-stable therapeutic antibodies , 2013, Biotechnology and Bioprocess Engineering.

[2]  Yong Jae Lee,et al.  Enhanced production of full-length immunoglobulin G via the signal recognition particle (SRP)-dependent pathway in Escherichia coli. , 2013, Journal of Biotechnology.

[3]  S. Jung,et al.  Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcγRIIa affinity and selectivity. , 2013, ACS chemical biology.

[4]  S. Lee,et al.  An engineered Escherichia coli having a high intracellular level of ATP and enhanced recombinant protein production , 2012, Applied Microbiology and Biotechnology.

[5]  Janice M. Reichert,et al.  Marketed therapeutic antibodies compendium , 2012, mAbs.

[6]  Pil Kim,et al.  An engineered Escherichia coli having a high intracellular level of ATP and enhanced recombinant protein production , 2011, Applied Microbiology and Biotechnology.

[7]  G. Georgiou,et al.  Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies. , 2011, Metabolic engineering.

[8]  K. Jeong,et al.  High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation , 2011, Bioprocess and biosystems engineering.

[9]  Seung Hoon Jang,et al.  Recombinant antibodies: Engineering and production in yeast and bacterial hosts , 2011, Biotechnology journal.

[10]  Yong-Sung Kim,et al.  Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris. , 2010, Protein expression and purification.

[11]  P. MacAry,et al.  Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain , 2010, PloS one.

[12]  S. Jung,et al.  Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[13]  D. Belin,et al.  Effects of Antibiotics and a Proto-Oncogene Homolog on Destruction of Protein Translocator SecY , 2009, Science.

[14]  Hirotada Mori,et al.  Glutathione production by efficient ATP-regenerating Escherichia coli mutants. , 2009, FEMS microbiology letters.

[15]  A. de Marco,et al.  Microbial Cell Factories Strategies for Successful Recombinant Expression of Disulfide Bond-dependent Proteins in Escherichia Coli , 2022 .

[16]  Bruce Tidor,et al.  Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors , 2008, Proceedings of the National Academy of Sciences.

[17]  C. Kaiser,et al.  High‐Level Production of Bacillus subtilis Glycine Oxidase by Fed‐Batch Cultivation of Recombinant Escherichia coli Rosetta (DE3) , 2008, Biotechnology progress.

[18]  M. Moo-young,et al.  Heterologous expression of lipase in Escherichia coli is limited by folding and disulfide bond formation , 2008, Applied Microbiology and Biotechnology.

[19]  S. Akilesh,et al.  FcRn: the neonatal Fc receptor comes of age , 2007, Nature Reviews Immunology.

[20]  Sang Woo Seo,et al.  Design of 5'-untranslated region variants for tunable expression in Escherichia coli. , 2007, Biochemical and biophysical research communications.

[21]  George Georgiou,et al.  Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli , 2007, Nature Biotechnology.

[22]  Brian F. Pfleger,et al.  Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes , 2006, Nature Biotechnology.

[23]  Stephen J Benkovic,et al.  Evolution of highly active enzymes by homology-independent recombination. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Baneyx,et al.  Recombinant protein folding and misfolding in Escherichia coli , 2004, Nature Biotechnology.

[25]  J. Betton,et al.  Protein quality control in the bacterial periplasm , 2004, Microbial cell factories.

[26]  S. Corisdeo,et al.  Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions. , 2004, Protein expression and purification.

[27]  Jon Beckwith,et al.  Protein disulfide bond formation in prokaryotes. , 2003, Annual review of biochemistry.

[28]  S. Lee,et al.  Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. , 2003, Biotechnology and bioengineering.

[29]  Jay D Keasling,et al.  Effect of gene location, mRNA secondary structures, and RNase sites on expression of two genes in an engineered operon. , 2002, Biotechnology and bioengineering.

[30]  L. Simmons,et al.  Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. , 2002, Journal of immunological methods.

[31]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[32]  S. Lee,et al.  High-Level Production of Human Leptin by Fed-Batch Cultivation of Recombinant Escherichia coli and Its Purification , 1999, Applied and Environmental Microbiology.

[33]  L. Simmons,et al.  Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli , 1996, Nature Biotechnology.

[34]  O. Fayet,et al.  Combined effects of the signal sequence and the major chaperone proteins on the export of human cytokines in Escherichia coli , 1996, Applied and environmental microbiology.

[35]  D. Yansura,et al.  Production of Monoclonal Antibodies in E. coli , 2010 .

[36]  S. Yoon,et al.  Secretory production of recombinant proteins in Escherichia coli. , 2010, Recent patents on biotechnology.

[37]  V. Ranade,et al.  Biotechnology: Pharmaceutical Aspects , 2010 .

[38]  A. Driessen,et al.  Sec-dependent preprotein translocation in bacteria , 1996, Archives of Microbiology.